ORAL CANCER AND MOUTHWASH USE = CANCER ORAL ET UTILISATION DES BAINS DE BOUCHEWYNDER EL; KABAT G; ROSENBERG S et al.1983; JOURNAL OF THE NATIONAL CANCER INSTITUTE; ISSN 0027-8874; USA; DA. 1983; VOL. 70; NO 2; PP. 255-260; ABS. ENG; BIBL. 25 REF.Article

CIGARETTE SMOKING AND MALIGNANT MELANOMA: PROGNOSTIC IMPLICATIONSRIGEL DS; FRIEDMAN RJ; LEVINE J et al.1981; J. DERMATOL. SURG. ONCOL.; ISSN 0148-0812; USA; DA. 1981; VOL. 7; NO 11; PP. 889-891; BIBL. 8 REF.Article

ABSENCE OF MUTAGENIC ACTIVITY OF THREE FORMS OF ASBESTOS IN LIVER EPITHELIAL CELLSREISS B; SOLOMON S; TONG C et al.1982; ENVIRON. RES. (NEW YORK); ISSN 0013-9351; USA; DA. 1982; VOL. 27; NO 2; PP. 389-397; BIBL. 3 P.Article

REGRESSION IN MALIGNANT MELANOMATRAU H; KOPF AW; RIGEL DS et al.1983; JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY; ISSN 0190-9622; USA; DA. 1983; VOL. 8; NO 3; PP. 363-368; BIBL. 26 REF.Article

Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension : results of the HALT studyPICKERING, T. G; LEVENSTEIN, M; WALMSLEY, P et al.American journal of hypertension. 1994, Vol 7, Num 9, pp 848-852, issn 0895-7061, 1Article

Nighttime dosing of doxazosin has peak effect on morning ambulatory blood pressure : results of the HALT studyPICKERING, T. G; LEVENSTEIN, M; WALMSLEY, P et al.American journal of hypertension. 1994, Vol 7, Num 9, pp 844-847, issn 0895-7061, 1Article

Principal results of the hypertension and lipid trial (HALT) : A multicenter study of doxazosin in patients with hypertensionLEVY, D; WALMSLEY, P; LEVENSTEIN, M et al.The American heart journal. 1996, Vol 131, Num 5, pp 966-973, issn 0002-8703Article

Simultaneous occurrence of subacute cutaneous lupus erythematosus and Sweet syndrome : a marker of Sjögren syndrome ?LEVENSTEIN, M. M; FISHER, B. K; FISHER, L. L et al.International journal of dermatology. 1991, Vol 30, Num 9, pp 640-643, issn 0011-9059Article

Prevalence of congenital-nevus-like nevi, nevi spili, and café au lait spotsKOPF, A. W; LEVINE, L. J; RIGEL, D. S et al.Archives of dermatology (1960). 1985, Vol 121, Num 6, pp 766-769, issn 0003-987XArticle

Accuracy in the clinical diagnosis of malignant melanomaGRIN, C. M; KOPF, A. W; WELKOVICH, B et al.Archives of dermatology (1960). 1990, Vol 126, Num 6, pp 763-766, issn 0003-987X, 4 p.Article

Recurrence rates of treated basal cell carcinomas. II, Curettage-electrodesiccationSILVERMAN, M. K; KOPF, A. W; GRIN, C. M et al.The Journal of dermatologic surgery and oncology. 1991, Vol 17, Num 9, pp 720-726, issn 0148-0812Article

Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndromeKOPF, A. W; LINDSAY, A. C; ROGERS, G. S et al.Journal of the American Academy of Dermatology. 1985, Vol 12, Num 4, pp 656-662, issn 0190-9622Article

Clinical characteristics of malignant melanomas developing in persons with dysplastiv NeviRIVERS, J. K; KOPF, A. W; VINOKUR, A. F et al.Cancer. 1990, Vol 65, Num 5, pp 1232-1236, issn 0008-543XArticle

Recurrence rates of treated basal cell carcinomas. IV: X-ray therapySILVERMAN, M. K; KOPF, A. W; GLADSTEIN, A. H et al.The Journal of dermatologic surgery and oncology. 1992, Vol 18, Num 7, pp 549-554, issn 0148-0812Article

Recurrence rates of treated basal cell carcinomas. I, OverviewSILVERMAN, M. K; KOPF, A. W; GRIN, C. M et al.The Journal of dermatologic surgery and oncology. 1991, Vol 17, Num 9, pp 713-718, issn 0148-0812Article

Dysplastic nevi: markers for increased risk for melanomaRIGEL, D. S; RIVERS, J. K; KOPF, A. W et al.Cancer. 1989, Vol 63, Num 2, pp 386-389, issn 0008-543XArticle

Influence of gender on survival in patients with stage I malignant melanomaVOSSAERT, K. A; SILVERMAN, M. K; KOPF, A. W et al.Journal of the American Academy of Dermatology. 1992, Vol 26, Num 3, pp 429-440, issn 0190-9622Article

Skin types in dysplastic nevus syndromeKOPF, A. W; GOLDMAN, R. J; RIVERS, J. K et al.The Journal of dermatologic surgery and oncology. 1988, Vol 14, Num 8, pp 827-831, issn 0148-0812Article

Hazard-rate analysis in stage I malignant melanomaROGERS, G. S; KOPF, A. W; RIGEL, D. S et al.Archives of dermatology (1960). 1986, Vol 122, Num 9, pp 999-1002, issn 0003-987XArticle

Efficacy and safety of fluoconazole prophylaxis for fungal infections after marrow transplantation : a prospective, randomized, double-blind studySLAVIN, M. A; OSBORNE, B; ADAMS, R et al.The Journal of infectious diseases. 1995, Vol 171, Num 6, pp 1545-1552, issn 0022-1899Article

STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34⁺ human bone marrow cells and is involved in the proliferation of early progenitor/stem cellsSMALL, D; LEVENSTEIN, M; CIVIN, C. I et al.Proceedings of the National Academy of Sciences of the United States of America. 1994, Vol 91, Num 2, pp 459-463, issn 0027-8424Article

Prospective follow-up for malignant melanoma in patients with atypical-mole (dysplastic-nevus) syndromeTIERSTEN, A. D; GRIN, C. M; KOPF, A. W et al.The Journal of dermatologic surgery and oncology. 1991, Vol 17, Num 1, pp 44-48, issn 0148-0812, 5 p.Article

Thickness of malignant melanoma: global analysis of related factorsKOPF, A. W; WELKOVICH, B; HENNESSEY, P et al.The Journal of dermatologic surgery and oncology. 1987, Vol 13, Num 4, pp 345-420, issn 0148-0812, 49 p.Serial Issue

Level of education and the risk of malignant melanomaLEE, P. Y; SILVERMAN, M. K; RIGEL, D. S et al.Journal of the American Academy of Dermatology. 1992, Vol 26, Num 1, pp 59-63, issn 0190-9622Article

Determination of preexcision surgical margins of melanomas from fixed-tissue specimens. DiscussionGOLOMB, F. M; DOYLE, J. P; GRIN, C. M et al.GOLOMB, F. M; Plastic and reconstructive surgery (1963). 1991, Vol 88, Num 5, pp 804-809, issn 0032-1052Article